You just read:

Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative

News provided by

ViiV Healthcare

04 Dec, 2014, 16:39 GMT